Broad Spectrum project: factors determining the quality of antibiotic use in primary care: an observational study protocol from Italy.
antibiotic
appropriate
attitudes
consumption
determinants
factors
family medicine
general practice
knowledge
prescription
questionnaire
use
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
06 07 2020
06 07 2020
Historique:
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
15
5
2021
Statut:
epublish
Résumé
The overuse of antibiotics is causing worldwide spread of antimicrobial resistance (AMR). Compared with other countries, Italy has both high antibiotic consumption rates and high rates of AMR. Due to the fact that around 90% of antibiotics are prescribed by general practitioners (GPs), this study aims to measure the impact of knowledge, attitudes and sociodemographic and workplace-related factors on the quality of antibiotic prescriptions filled by GPs in the Italian Region of Sardinia. Knowledge, attitude, sociodemographic and workplace-related factors deemed to influence physicians prescribing behaviour will be evaluated in a cross-sectional study conducted among all GPs of the Italian Region of Sardinia (n=1200). A knowledge and attitudes questionnaire (Knowledge and Attitudes on Antibiotics and Resistance - Italian version: ITA-KAAR) accompanied by a sociodemographic form will be linked to drug prescription data reimbursed by the National Health System. European Surveillance of Antibiotic Consumption quality indicators for outpatient antibiotic use will be calculated from drug prescription records. Every GP will be deemed to have demonstrated an adequate quality of prescriptions of antibiotics if half of the indicator score plus one is better than the median of the region. A multivariate Poisson regression model with robust variance estimation will be used to evaluate the impact of the determinants of antibiotic prescriptions on the actual prescribing quality of each physician. The project has been approved by the ethics committee of the Regional Health Trust of Sardinia (176/2019/CE, 24 September 2019). The results will be useful to inform evidence-based interventions to tackle irrational antibiotic use in the community.
Identifiants
pubmed: 32636291
pii: bmjopen-2020-038843
doi: 10.1136/bmjopen-2020-038843
pmc: PMC7342852
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e038843Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA Netw Open. 2018 Jun 1;1(2):e180243
pubmed: 30646067
Lancet Infect Dis. 2014 Aug;14(8):742-750
pubmed: 25022435
Expert Rev Anti Infect Ther. 2016;14(4):403-13
pubmed: 26853235
Recenti Prog Med. 2020 Jun;111(6):368-370
pubmed: 32573552
Qual Saf Health Care. 2007 Dec;16(6):440-5
pubmed: 18055888
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
Eur J Clin Pharmacol. 2010 Jul;66(7):743-8
pubmed: 20429000
Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):655-666
pubmed: 30014725
J Antimicrob Chemother. 2016 Oct;71(10):2972-9
pubmed: 27353468
Eur J Clin Pharmacol. 2006 Dec;62(12):1055-64
pubmed: 17021889
BMC Pediatr. 2016 Dec 5;16(1):203
pubmed: 27919244
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763
Br J Gen Pract. 2014 Dec;64(629):604-5
pubmed: 25452508
BMC Infect Dis. 2016 Jan 08;16:7
pubmed: 26746228
BMC Med Res Methodol. 2017 Dec 2;17(1):157
pubmed: 29197347
Curr Med Res Opin. 2020 Feb;36(2):301-327
pubmed: 31794332
BMJ Qual Saf. 2011 Mar 21;20(9):764-772
pubmed: 21441602
Antimicrob Resist Infect Control. 2019 Aug 7;8:132
pubmed: 31406571
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Aust N Z J Public Health. 2008 Jun;32(3):288-9
pubmed: 18578832
J Med Internet Res. 2018 Jan 23;20(1):e24
pubmed: 29362206
BMC Public Health. 2015 Sep 17;15:908
pubmed: 26381376
Lancet Infect Dis. 2019 Dec;19(12):1278-1280
pubmed: 31782385
Lancet Infect Dis. 2018 Jan;18(1):18-20
pubmed: 29303731
J Antimicrob Chemother. 2019 Sep 1;74(9):2788-2796
pubmed: 31257435
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
Front Pharmacol. 2019 Mar 05;9:1156
pubmed: 30890943
Lancet Glob Health. 2019 Jul;7(7):e861-e871
pubmed: 31200888
BMJ Open. 2017 Oct 15;7(10):e017522
pubmed: 29038184
Int J Antimicrob Agents. 2013 Mar;41(3):203-12
pubmed: 23127482
Health Qual Life Outcomes. 2014 Dec 09;12:176
pubmed: 25492701
BMC Infect Dis. 2014 Jan 09;14:13
pubmed: 24405683
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
PLoS One. 2015 Oct 28;10(10):e0141820
pubmed: 26509966
Int J Public Health. 2010 Oct;55(5):469-78
pubmed: 20603713
Antimicrob Resist Infect Control. 2018 Apr 25;7:58
pubmed: 29713465